Clinical Trial Update: Efficacy Study of a Maintenance Therapy With Immunomodulator MGN1703 in Patients With Advanced Colorectal Carcinoma [Phase 2]

View source ↗

Summary

Phase 2 efficacy study of maintenance therapy with immunomodulator MGN1703 in advanced colorectal cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Colorectal Cancer

Drugs mentioned

• MGN1703 (MGN1703)

Snippet

Sponsor: Mologen AG | Conditions: Advanced Colorectal Carcinoma | Phase 2 | Status: COMPLETED